BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28119061)

  • 21. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.
    Kobi D; Steunou AL; Dembélé D; Legras S; Larue L; Nieto L; Davidson I
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):404-18. PubMed ID: 20337985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
    Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
    J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
    Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
    Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane.
    Fisher ML; Adhikary G; Grun D; Kaetzel DM; Eckert RL
    Mol Carcinog; 2016 Dec; 55(12):2024-2036. PubMed ID: 26693692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
    Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
    J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.
    Wang Y; Ou Z; Sun Y; Yeh S; Wang X; Long J; Chang C
    Oncogene; 2017 Mar; 36(12):1644-1654. PubMed ID: 27869170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
    Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
    Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
    BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry.
    Stanisz H; Saul S; Müller CS; Kappl R; Niemeyer BA; Vogt T; Hoth M; Roesch A; Bogeski I
    Pigment Cell Melanoma Res; 2014 May; 27(3):442-53. PubMed ID: 24472175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
    Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
    Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MITF, the Janus transcription factor of melanoma.
    Koludrovic D; Davidson I
    Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.
    Vivas-García Y; Falletta P; Liebing J; Louphrasitthiphol P; Feng Y; Chauhan J; Scott DA; Glodde N; Chocarro-Calvo A; Bonham S; Osterman AL; Fischer R; Ronai Z; García-Jiménez C; Hölzel M; Goding CR
    Mol Cell; 2020 Jan; 77(1):120-137.e9. PubMed ID: 31733993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.
    Chen L; Ma D; Li Y; Li X; Zhao L; Zhang J; Song Y
    Int J Mol Med; 2018 Mar; 41(3):1275-1282. PubMed ID: 29286144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
    Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
    PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cells.
    Gunarta IK; Li R; Nakazato R; Suzuki R; Boldbaatar J; Suzuki T; Yoshioka K
    Cancer Sci; 2017 Aug; 108(8):1602-1611. PubMed ID: 28635133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination.
    Pinner S; Jordan P; Sharrock K; Bazley L; Collinson L; Marais R; Bonvin E; Goding C; Sahai E
    Cancer Res; 2009 Oct; 69(20):7969-77. PubMed ID: 19826052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.